Niagen^®+ is a patented form of nicotinamide riboside, a unique precursor to NAD+ (nicotinamide adenine dinucleotide). Nicotinamide riboside is listed on Category I of FDA’s interim list of substances that may be used in compounding at Section 503B outsourcing facilities.  Clinical studies have shown nicotinamide riboside increases NAD+ levels in the body, which plays a crucial role in cellular energy production, DNA repair, and overall cellular health. As we age, NAD+ levels naturally decline (Massudi et al., 2012; Janssens et al., 2022), which can contribute to decreased vitality and other signs of aging. Niagen^®+ (nicotinamide riboside) can help to restore NAD+ levels, supporting healthy aging, increased cellular energy, and improved cellular function. Trusted by healthcare professionals, Niagen^®+ may help maintain optimal wellness.